Sequential use of the androgen synthesis inhibitors ketoconazole and abiraterone acetate in castration-resistant prostate cancer and the predictive value of circulating androgens

PURPOSE: Patients previously treated with ketoconazole were excluded from phase III trials of abiraterone acetate due to potential overlapping mechanism of action. The purpose of this study was to determine the clinical utility of abiraterone and its impact on circulating androgens following ketocon...

ver descrição completa

Na minha lista:
Detalhes bibliográficos
Publicado no:Clin Cancer Res
Main Authors: Kim, Won, Zhang, Li, Wilton, John H., Fetterly, Gerald, Mohler, James L., Weinberg, Vivian, Morse, Allison, Szmulewitz, Russell, Friedlander, Terence W., Fong, Lawrence, Lin, Amy M., Harzstark, Andrea, Molina, Arturo, Small, Eric J., Ryan, Charles J.
Formato: Artigo
Idioma:Inglês
Publicado em: 2014
Assuntos:
Article
Acesso em linha:https://ncbi.nlm.nih.gov/pmc/articles/PMC4277885/
https://ncbi.nlm.nih.gov/pubmed/25336698
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1158/1078-0432.CCR-14-1595
Tags: Adicionar Tag
Sem tags, seja o primeiro a adicionar uma tag!

Registos relacionados